Search

everythinglearnresearchcommunity

for

Search:↓

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

RF-based therapies might help treat hair loss.

New small molecule drugs could help treat hair loss.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Using fractional CO2 laser with halometasone cream works better for chronic hand eczema than just the cream, improving symptoms and quality of life with fewer relapses.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

JAK inhibitors might help treat alopecia areata.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Upadacitinib may effectively treat resistant lichen planopilaris.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.